IGI Securities Limited – Investor Kit – Top News (20-05-2020)

Lahore, May 20, 2020 (PPI-OT): GSK to discontinue manufacturing, supply of Zantac products

Pharmaceutical company GlaxoSmithKline Pakistan Limited (GSK) has decided to discontinue the manufacture and supply of the Ranitidine brand (Zantac), informed the company in a statement to the Pakistan Stock Exchange on Tuesday. As noted by the European Medicines Agency (EMA), there are alternatives medicines to Ranitidine available, the statement added.

Leave a Reply